초음파 내시경검사(EUS) 시장 예측(-2029년) : 제품별, 유형별, 용도별, 최종사용자별, 지역별

The endoscopic ultrasonography market is projected to reach USD 1.93 billion by 2029 from USD 1.37 billion in 2024, at a CAGR of 7.1% during the forecast period. The endoscopic ultrasonography market has had strong growth due to a number of factors such as the rising incidences of cancer, growing initiatives to develop healthcare infrastructure in underdeveloped regions, increasing preference for minimally invasive surgeries, and advancements in endoscopic procedures.

"By product type, endoscopes segment is expected to account for the largest share in the endoscopic ultrasonography market."

The endoscopes segment accounted for the largest share of the endoscopic ultrasonography market in the forecast period. The increasing demand for minimally invasive procedures, coupled with advancements in technology enhancing precision and control, are significant drivers. Moreover, the rising prevalence of gastrointestinal disorders necessitates more efficient and accurate diagnostic and therapeutic procedures, further boosting the adoption of endoscopes. These factors collectively contribute to the growth potential for this segment within the market.

"Diagnostics segment, by type is expected to have the largest market share in the endoscopic ultrasonography market"

Based on type, the diagnostics segment is expected to dominate the endoscopic ultrasonography market due to the increasing demand for early and accurate detection of chronic diseases coupled with advancements in imaging technology, providing real-time visualization and high-resolution images. Moreover, rising adoption of EUS-guided fine needle aspiration procedures worldwide, driven by their minimally invasive nature and associated benefits like shorter recovery times and reduced post-operative complications have further boosted the growth in this segment, thereby indicating promising growth potential within the endoscopic ultrasonography market.

"The gastrointestinal disorders segment accounted the second-largest market share in the endoscopic ultrasonography market."

By application, the gastrointestinal disorders segment accounted for the second-largest market share in the endoscopic ultrasonography market. This significant share can be attributed to the rising prevalence of gastrointestinal disorders such as gastric cancer, chronic pancreatitis, and pancreatic cancer. Moreover, the growing geriatric population which is more prone to gastrointestinal diseases increasingly demand for advanced diagnostic procedures. These factors' all together play a significant role in propelling market growth.

"Hospitals segment of the endoscopic ultrasonography market is expected to have largest share."

Based on end user, the hospitals segment of the endoscopic ultrasonography market is expected to hold the largest share during the forecast period owing to the factors like the availability of advanced infrastructure constituting broad range of advanced diagnostic and therapeutic techniques, coupled with skilled professionals like gastroenterologists and endoscopists. Moreover, hospitals serving as vital healthcare centers, continuously invest in innovative endoscopic ultrasonography devices to address evolving healthcare demands, thus propelling market growth.

"Asia Pacific to hold third largest market share in the endoscopic ultrasonography market during the forecast period."

The Asia Pacific region accounted the third largest share in the endoscopic ultrasonography market in the forecast period. The growth is attributed to several factors, including the growing advanced healthcare infrastructure, widespread acceptance of innovative medical devices, and increasing healthcare expenditure in Asia Pacific region. Additionally, the ongoing enhancements in endoscopic technologies are anticipated to increase the demand for endoscopic ultrasonography devices in APAC region.

A breakdown of the primary participants (supply side) for the endoscopic ultrasonography market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-20%, and Tier 3-45%
• By Designation: C-level-35%, Director Level- 45%, and Others-20%
• By Region: North America-40%, Europe-30%, Asia Pacific-20%, Latin America-5%, and Middle East & Africa-5%

Prominent players in the endoscopic ultrasonography market include Olympus Corporation (Japan), Medtronic (US), FUJIFILM Holdings Corporation (Japan), Boston Scientific Corporation (US), PENTAX Medical (Japan), Steris (Ireland), CONMED Corporation (US), Lepu Medical Technology(Beijing)Co., Ltd. (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), Cook (US), Huaco Healthcare Technologies Co. Ltd.(China), SonoScape Medical Corp.(China), Endosound, Inc.(US), Limaca-Medical (Israel), Beijing ZKSK Technology Co., Ltd. (China), Kaigen Pharma Co., Ltd.(Japan), PIOLAX MEDICAL DEVICES, INC.(Japan), Micro-Tech Endoscopy (US), Shaili Endoscopy (India), Zhejiang Soudon Medical Technology Co., Ltd.(China), ENDO-FLEX GmbH. (Germany), Ace Medical Devices Pvt. Ltd. (India), Medi-Globe GmbH.(Arizona), Medorah Meditek Pvt. Ltd.(India), and InnerMedical Co., Ltd. (China).

Research Coverage:

The report analyzes the endoscopic ultrasonography market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall endoscopic ultrasonography market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing requirement for endoscopy procedures to diagnose and treat target diseases, rising incidence of gastrointestinal disorders and colorectal cancer, increased investments, funds, and grants by government bodies and other organizations, technological advancements in endoscopic ultrasonography devices), restraints (high costs of endoscopic ultrasonography procedures, and complications and limitations of endoscopic ultrasonography), opportunities (high market growth potential in emerging economies, and increasing preference for minimally invasive surgeries) and challenges (increasing number of product recalls).
• Market Penetration: It includes extensive information on products offered by the major players in the global the endoscopic ultrasonography market. The report includes various segments in product, type, application, end user and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global endoscopic ultrasonography market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the endoscopic ultrasonography market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global endoscopic ultrasonography market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources of secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Key primary insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
  • 2.2.3 DEMAND-SIDE APPROACH
  • 2.2.4 VOLUME DATA ANALYSIS
  • 2.2.5 PROCEDURE DATA ANALYSIS
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ENDOSCOPIC ULTRASOUND MARKET OVERVIEW
• 4.2 ASIA PACIFIC: ENDOSCOPIC ULTRASOUND MARKET, BY END USER AND COUNTRY, 2023
• 4.3 ENDOSCOPIC ULTRASOUND MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 ENDOSCOPIC ULTRASOUND MARKET: REGIONAL MIX
• 4.5 ENDOSCOPIC ULTRASOUND MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing requirement for endoscopy procedures to diagnose and treat target diseases
    • 5.2.1.2 Rising incidence of gastrointestinal disorders and colorectal cancer
    • 5.2.1.3 Increased investments, funds, and grants by government bodies and other organizations
    • 5.2.1.4 Technological advancements in endoscopic ultrasound devices
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High costs of endoscopic ultrasound procedures
    • 5.2.2.2 Complications and limitations of endoscopic ultrasound
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High market growth potential in emerging economies
    • 5.2.3.2 Increasing preference for minimally invasive surgeries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Increasing number of product recalls
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ULTRASOUND CAPSULE ENDOSCOPY
  • 5.3.2 ENDOSCOPIC ULTRASOUND-GUIDED SHEAR WAVE ELASTOGRAPHY
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 Contrast-enhanced endoscopic ultrasound
    • 5.6.1.2 Lumen-apposing metal stents
  • 5.6.2 COMPLEMENTARY TECHNOLOGIES
    • 5.6.2.1 Elastography
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF SUPPLIERS
  • 5.7.4 BARGAINING POWER OF BUYERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.8.2 KEY BUYING CRITERIA
• 5.9 REGULATORY ANALYSIS
  • 5.9.1 REGULATORY FRAMEWORK
    • 5.9.1.1 North America
      • 5.9.1.1.1 US
      • 5.9.1.1.2 Canada
    • 5.9.1.2 Europe
      • 5.9.1.2.1 Germany
      • 5.9.1.2.2 France
      • 5.9.1.2.3 UK
      • 5.9.1.2.4 Italy
  • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.10 PRICING ANALYSIS
  • 5.10.1 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY KEY PLAYER, 2021-2023
  • 5.10.2 AVERAGE SELLING PRICE TREND OF ENDOSCOPIC ULTRASOUND PRODUCTS, BY REGION, 2021-2023
• 5.11 ECOSYSTEM ANALYSIS
  • 5.11.1 ROLE IN ECOSYSTEM
• 5.12 PATENT ANALYSIS
  • 5.12.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC ULTRASOUND
  • 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.13 TRADE ANALYSIS
  • 5.13.1 IMPORT DATA FOR HS CODE 901890
  • 5.13.2 EXPORT DATA FOR HS CODE 901890
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 UNMET NEEDS/END-USER EXPECTATIONS
• 5.16 IMPACT OF AI/GEN AI ON ENDOSCOPIC ULTRASOUND MARKET
• 5.17 CASE STUDY ANALYSIS
• 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.19 ADJACENT MARKETS
• 5.20 INVESTMENT & FUNDING SCENARIO

6 ENDOSCOPIC ULTRASOUND MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 ENDOSCOPES
  • 6.2.1 RADIAL ENDOSCOPES
    • 6.2.1.1 High image quality, improved penetration depth, and excellent maneuverability to propel segment growth
  • 6.2.2 LINEAR ENDOSCOPES
    • 6.2.2.1 Improved real-time targeting of lesions and better clinical management to aid segment growth
• 6.3 ULTRASOUND PROCESSORS
  • 6.3.1 ULTRASOUND PROCESSORS TO PRECISELY DETECT ABNORMALITIES AND FACILITATE BETTER TREATMENT PLANNING
• 6.4 ULTRASOUND PROBES
  • 6.4.1 CONSTANT INNOVATIONS AND ADVANCEMENTS TO AUGMENT MARKET GROWTH
• 6.5 ULTRASOUND NEEDLES
  • 6.5.1 FINE NEEDLE ASPIRATION
    • 6.5.1.1 Superior accuracy and effectiveness in staging cancer to fuel segment growth
  • 6.5.2 FINE NEEDLE BIOPSIES
    • 6.5.2.1 Improved diagnostic accuracy in pancreatic and non-pancreatic lesions to boost segment growth
  • 6.5.3 OTHER ULTRASOUND NEEDLES
• 6.6 ACCESSORIES
  • 6.6.1 INCREASING ADOPTION OF ACCESSORIES FOR BETTER EFFICIENCY, PRECISION, AND SAFETY OF PROCEDURES TO DRIVE MARKET

7 ENDOSCOPIC ULTRASOUND MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 DIAGNOSTICS
  • 7.2.1 RISING PREVALENCE OF GASTROINTESTINAL DISEASES TO PROPEL MARKET GROWTH
• 7.3 THERAPEUTICS
  • 7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE PROCEDURES FOR PANCREATIC DISORDERS TO AID SEGMENT GROWTH

8 ENDOSCOPIC ULTRASOUND MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 ONCOLOGY
  • 8.2.1 UPPER GASTROINTESTINAL ONCOLOGY
    • 8.2.1.1 Increasing incidence of esophageal and gastric cancers to drive segment
  • 8.2.2 LOWER GASTROINTESTINAL ONCOLOGY
    • 8.2.2.1 High prevalence of colorectal cancer to support segment growth
• 8.3 GASTROINTESTINAL DISORDERS
  • 8.3.1 PANCREATIC DISORDERS
    • 8.3.1.1 Rising burden of chronic pancreatic diseases to aid segment growth
  • 8.3.2 OTHER GASTROINTESTINAL DISORDERS
• 8.4 OTHER APPLICATIONS

9 ENDOSCOPIC ULTRASOUND MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 INCREASED DEMAND FOR ADVANCED IMAGING TECHNIQUES AND PRECISE DIAGNOSTICS TO SPUR MARKET GROWTH
• 9.3 AMBULATORY SURGERY CENTERS
  • 9.3.1 COST-EFFECTIVENESS AND HIGH REIMBURSEMENT RATES TO PROPEL MARKET GROWTH
• 9.4 OTHER END USERS

10 ENDOSCOPIC ULTRASOUND MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American endoscopic ultrasound market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Rising incidence of cancer and increasing focus on early disease detection to propel market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Increased healthcare spending and favorable research initiatives to spur market growth
  • 10.3.3 UK
    • 10.3.3.1 High government healthcare funding to support market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Advancements in healthcare and favorable national health insurance to fuel market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Rising geriatric population and increasing focus on cancer care to propel market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 High prevalence of lifestyle-related cancer risk and increased healthcare expenditure to augment market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Favorable government health insurance schemes and high geriatric population to aid market growth
  • 10.4.3 CHINA
    • 10.4.3.1 Large patient pool and high obesity rates to drive market
  • 10.4.4 INDIA
    • 10.4.4.1 Increasing prevalence of cancer and improved government healthcare initiatives to aid market growth
  • 10.4.5 SOUTH KOREA
    • 10.4.5.1 High incidence of gastrointestinal diseases and cancer among aged population to fuel market growth
  • 10.4.6 AUSTRALIA
    • 10.4.6.1 Increased patient volume and favorable government initiatives to drive market
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 High risk of chronic diseases among geriatric population to propel market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Improved healthcare infrastructure and increased cancer awareness to augment market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Increasing healthcare infrastructure development and investment to support market growth
  • 10.6.3 REST OF MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPIC ULTRASOUND MARKET
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Type footprint
    • 11.5.5.5 Application footprint
    • 11.5.5.6 End-user footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key startups/SMEs
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 R&D ASSESSMENT OF KEY PLAYERS
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 PRODUCT LAUNCHES & APPROVALS
  • 11.10.2 EXPANSIONS
  • 11.10.3 DEALS
  • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 OLYMPUS CORPORATION
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches & approvals
      • 12.1.1.3.2 Deals
      • 12.1.1.3.3 Expansions
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 MEDTRONIC
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product approvals
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 FUJIFILM HOLDINGS CORPORATION
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches & approvals
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Other developments
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 BOSTON SCIENTIFIC CORPORATION
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product approvals
      • 12.1.4.3.2 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 PENTAX MEDICAL
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches & approvals
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 STERIS
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Deals
      • 12.1.6.3.2 Expansions
  • 12.1.7 CONMED CORPORATION
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Deals
  • 12.1.8 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product approvals
  • 12.1.9 CANON MEDICAL SYSTEMS CORPORATION
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
  • 12.1.10 COOK
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches
      • 12.1.10.3.2 Deals
      • 12.1.10.3.3 Expansions
• 12.2 OTHER PLAYERS
  • 12.2.1 HUACO HEALTHCARE TECHNOLOGIES CO., LTD.
  • 12.2.2 SONOSCAPE MEDICAL CORP.
  • 12.2.3 ENDOSOUND, INC.
  • 12.2.4 LIMACA-MEDICAL
  • 12.2.5 BEIJING ZKSK TECHNOLOGY CO., LTD.
  • 12.2.6 KAIGEN PHARMA CO., LTD.
  • 12.2.7 PIOLAX MEDICAL DEVICES, INC.
  • 12.2.8 MICRO-TECH ENDOSCOPY
  • 12.2.9 SHAILI ENDOSCOPY
  • 12.2.10 ZHEJIANG SOUDON MEDICAL TECHNOLOGY CO., LTD.
  • 12.2.11 ENDO-FLEX GMBH
  • 12.2.12 ACE MEDICAL DEVICES PVT. LTD.
  • 12.2.13 MEDI-GLOBE GMBH
  • 12.2.14 MEDORAH MEDITEK PVT. LTD.
  • 12.2.15 INNERMEDICAL CO., LTD.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS